Albireo pharma, inc. (ALBO)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Sep'16Dec'15Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09
Revenue

9,636

12,740

1

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

11,364

-

5,099

-

0

0

0

0

0

0

Operating expenses:
Research and development

45,575

31,732

12,991

8,077

3,682

5,634

13,365

14,194

14,296

12,315

13,597

26,177

32,325

Government grants

-

-

-

-

-

-

-

531

546

88

0

0

-

General and administrative

22,963

18,061

15,246

15,786

10,289

4,462

6,402

5,598

6,843

7,072

9,625

10,980

10,994

Other operating expense, net

-2,210

-837

3,659

205

-

271

-

-

-

-

-

-

-

Total operating expenses

70,748

50,630

24,578

23,658

13,971

9,825

19,767

19,261

20,593

19,299

23,222

37,157

43,319

Operating loss

-61,112

-37,890

-24,577

-12,294

-

-4,726

-

-

-

-

-

-

-

Interest expense, net

-5,296

-4,838

40

-1,319

-

-1,722

-

-

-

-

-

-

-

Non-operating income (expense), net

3,691

-3,363

335

-2,675

-

-320

-

-

-

-

-

-

-

Interest and other income

-

-

-

-

264

-

52

49

56

80

60

17

386

Interest expense

-

-

-

-

-

-

-

-

-

0

0

0

-

Adjustments to fair value of common stock warrant liability

-

-

-

-

4

-

1,009

5,107

1,217

-1,510

12,611

-1,254

-

Loss on fixed asset

-

-

-

-

-

-

-2

0

-

-

-

-

-

Loss on settlement of debt

-

-

-

-

-

-

-

-

-

0

0

0

-

Net loss before income taxes

-62,717

-46,091

-24,202

-16,288

-13,703

-6,768

-18,708

-14,105

-19,320

-20,729

-10,551

-38,394

-42,933

Income tax

-

20

212

62

52

0

29

26

15

18

41

-104

337

Net loss

-62,717

-46,111

-24,414

-16,350

-13,755

-6,768

-18,737

-14,131

-19,335

-20,747

-10,592

-38,290

-43,270

Net loss per share attributable to holders of common stock:
Charge for accretion of beneficial conversion rights

-

-

-

-

-

-

-

-

-

0

0

0

-

Deemed dividend - warrants

-

-

-

-

-

-

-

-

-

0

0

0

-

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-20,747

-10,592

-38,290

-43,270

Net loss per common share - basic and diluted

-5.04

-3.94

-3.12

-13.19

-6.45

-25.49

-13.70

-0.66

-1.24

-1.91

-1.36

-6.34

-1.82

Weighted-average shares outstanding:
Weighted-average common shares used to compute basic and diluted net loss per common share

12,437

11,702

7,819

1,239

2,133

265

1,367

21,404

15,650

10,882

7,788

6,040

-

Weighted average shares outstanding - basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

23,746